Stocks and Investing Stocks and Investing
Mon, April 18, 2022
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (VMC) at Hold with Decreased Target to $224 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
Connor Lynagh Maintained (VLO) at Buy with Increased Target to $125 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Todd Maintained (VLO) at Buy with Increased Target to $121 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
David Koning Maintained (V) at Buy and Held Target at $290 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
Ebrahim Poonawala Maintained (USB) at Hold with Increased Target to $56 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Strelzik Downgraded (WEN) to Hold and Decreased Target to $22 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (WFC) at Hold with Decreased Target to $60 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
David Long Maintained (WFC) at Buy with Decreased Target to $60 on, Apr 18th, 2022
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (WFC) at Buy with Increased Target to $64 on, Apr 18th, 2022
Sun, April 17, 2022
[ 12:00 AM ] - WOPRAI
John Pancari Maintained (WFC) at Buy and Held Target at $55 on, Apr 17th, 2022
[ 12:00 AM ] - WOPRAI
Ken Usdin Maintained (WFC) at Strong Buy and Held Target at $55 on, Apr 17th, 2022
Thu, April 14, 2022
[ 12:00 AM ] - WOPRAI
Steve Scala Maintained (ABBV) at Buy with Increased Target to $180 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Damian Karas Maintained (ZBRA) at Strong Buy with Decreased Target to $600 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (AGCO) at Hold with Increased Target to $143 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Dan Levy Initiated (AEVA) at Buy and Held Target at $30 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Elemer Piros Downgraded (APLS) to Strong Sell and Held Target at $40 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Kash Rangan Maintained (BASE) at Hold with Decreased Target to $28 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Gavin Parsons Maintained (BAH) at Strong Buy with Increased Target to $102 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Sean Horgan Maintained (CBOE) at Strong Buy with Increased Target to $154 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
John Glass Maintained (CAKE) at Sell with Decreased Target to $36 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Gavin Parsons Maintained (CACI) at Hold with Increased Target to $336 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Michael Phillips Maintained (ALL) at Hold with Increased Target to $152 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Juan Sanabria Initiated (AMH) at Buy and Held Target at $46 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Robert Lee Maintained (BLK) at Hold with Decreased Target to $803 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (BLK) at Hold with Decreased Target to $734 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (BLK) at Strong Buy with Decreased Target to $905 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (BLK) at Buy with Decreased Target to $932 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
John Glass Maintained (BLMN) at Hold with Decreased Target to $25 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Maintained (BXP) at Strong Buy with Increased Target to $139 on, Apr 14th, 2022
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (BTAI) at Strong Bu .. with Increased Target to $134 on, Apr 14th, 2022

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Increased Target to $134 on, Apr 14th, 2022


Published on 2024-10-27 20:27:52 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $130 to $134 on, Apr 14th, 2022.

Raghuram has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram

  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $25 on, Wednesday, February 16th, 2022
Contributing Sources